← All companies

STLN

The Oncology Institute, Inc.

STLN Nasdaq Services-Offices & Clinics of Doctors of Medicine EDGAR ↗

$6.14

-0.03 -0.41%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

$625M

Revenue (TTM) ⓘ

$587M

Net income (TTM) ⓘ

$60.6B

EPS (TTM) ⓘ

$-0.28

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

-$27.8M

Cash ⓘ

$41.1M

Total assets ⓘ

$178M

Gross margin ⓘ

—

52-week range ⓘ

$2.32 – $7.05

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 6, 2026

8-K Results of operations (earnings release) Aug 6, 2026

8-K Amended charter or bylaws; Regulation FD disclosure Aug 3, 2026

8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jul 7, 2026

8-K Shareholder vote results Jun 18, 2026

8-K Item 1.05 May 22, 2026

8-K Results of operations (earnings release) May 7, 2026

10-Q Quarter ended 2026-03-31 May 7, 2026

8-K Regulation FD disclosure Mar 13, 2026

10-K Fiscal year ended 2025-12-31 Mar 12, 2026

8-K Results of operations (earnings release) Mar 12, 2026

8-K Director or officer change; Regulation FD disclosure Feb 23, 2026

8-K Results of operations (earnings release) Jan 12, 2026

8-K Director or officer change; Regulation FD disclosure Jan 7, 2026

8-K Director or officer change; Regulation FD disclosure Dec 1, 2025

8-K Regulation FD disclosure Nov 14, 2025

10-Q Quarter ended 2025-09-30 Nov 13, 2025

8-K Results of operations (earnings release) Nov 13, 2025

8-K Regulation FD disclosure Nov 6, 2025

10-Q Quarter ended 2025-06-30 Aug 13, 2025

8-K Results of operations (earnings release) Aug 13, 2025

8-K Director or officer change; Regulation FD disclosure Aug 13, 2025

8-K Regulation FD disclosure May 19, 2025

8-K Results of operations (earnings release) May 14, 2025

10-Q Quarter ended 2025-03-31 May 14, 2025

8-K Shareholder vote results May 8, 2025

8-K Director or officer change May 7, 2025

8-K Other events Apr 11, 2025

8-K Entered a material agreement; Unregistered sale of equity Mar 27, 2025

10-K Fiscal year ended 2024-12-31 Mar 26, 2025

8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Mar 25, 2025

8-K Regulation FD disclosure Mar 24, 2025

8-K Results of operations (earnings release) Mar 24, 2025

8-K Entered a material agreement; Regulation FD disclosure Feb 26, 2025

8-K Delisting notice or listing-rule failure Dec 19, 2024

10-Q Quarter ended 2024-09-30 Nov 13, 2024

8-K Results of operations (earnings release) Nov 13, 2024

8-K Director or officer change Nov 12, 2024

8-K Director or officer change; Regulation FD disclosure Sep 23, 2024

10-Q Quarter ended 2024-06-30 Aug 13, 2024